Millns H - Search Results

1

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.

Richards D, Millns H, Cookson L, Lukas MA. Richards D, et al. Among authors: millns h. Orphanet J Rare Dis. 2022 Jul 9;17(1):259. doi: 10.1186/s13023-022-02405-7. Orphanet J Rare Dis. 2022. PMID: 35810311 Free PMC article. Clinical Trial.

2

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study.

Wechalekar A, Antoni G, Al Azzam W, Bergström M, Biswas S, Chen C, Cheriyan J, Cleveland M, Cookson L, Galette P, Janiczek RL, Kwong RY, Lukas MA, Millns H, Richards D, Schneider I, Solomon SD, Sörensen J, Storey J, Thompson D, van Dongen G, Vugts DJ, Wall A, Wikström G, Falk RH. Wechalekar A, et al. Among authors: millns h. BMC Cardiovasc Disord. 2022 Feb 13;22(1):49. doi: 10.1186/s12872-021-02407-6. BMC Cardiovasc Disord. 2022. PMID: 35152886 Free PMC article. Clinical Trial.

3

Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.

Turner RC, Millns H, Holman RR. Turner RC, et al. Among authors: millns h. Diabetologia. 1997 Jul;40 Suppl 2:S121-2. doi: 10.1007/s001250051424. Diabetologia. 1997. PMID: 9248716 Review. No abstract available.

4

Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.

Ratti E, Bettica P, Alexander R, Archer G, Carpenter D, Evoniuk G, Gomeni R, Lawson E, Lopez M, Millns H, Rabiner EA, Trist D, Trower M, Zamuner S, Krishnan R, Fava M. Ratti E, et al. Among authors: millns h. J Psychopharmacol. 2013 May;27(5):424-34. doi: 10.1177/0269881113480990. Epub 2013 Mar 28. J Psychopharmacol. 2013. PMID: 23539641 Clinical Trial.

5

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23).

Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. Turner RC, et al. Among authors: millns h. BMJ. 1998 Mar 14;316(7134):823-8. doi: 10.1136/bmj.316.7134.823. BMJ. 1998. PMID: 9549452 Free PMC article.

6

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.

Davis TM, Millns H, Stratton IM, Holman RR, Turner RC. Davis TM, et al. Among authors: millns h. Arch Intern Med. 1999 May 24;159(10):1097-103. doi: 10.1001/archinte.159.10.1097. Arch Intern Med. 1999. PMID: 10335687

7

Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.

Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R, Warren-Perry M, Zhang Y, Millns H, Turner R, Province M, Bryan J, Permutt MA, Aguilar-Bryan L. Inoue H, et al. Among authors: millns h. Diabetes. 1996 Jun;45(6):825-31. doi: 10.2337/diab.45.6.825. Diabetes. 1996. PMID: 8635661

8

Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM.

Inoue H, Ferrer J, Warren-Perry M, Zhang Y, Millns H, Turner RC, Elbein SC, Hampe CL, Suarez BK, Inagaki N, Seino S, Permutt MA. Inoue H, et al. Among authors: millns h. Diabetes. 1997 Mar;46(3):502-7. doi: 10.2337/diab.46.3.502. Diabetes. 1997. PMID: 9032109

9

Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro.

Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM. Sakura H, et al. Among authors: millns h. Diabetologia. 1996 Oct;39(10):1233-6. doi: 10.1007/BF02658512. Diabetologia. 1996. PMID: 8897013

10

Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials.

Wagenlehner F, Perry CR, Hooton TM, Scangarella-Oman NE, Millns H, Powell M, Jarvis E, Dennison J, Sheets A, Butler D, Breton J, Janmohamed S. Wagenlehner F, et al. Among authors: millns h. Lancet. 2024 Feb 24;403(10428):741-755. doi: 10.1016/S0140-6736(23)02196-7. Epub 2024 Feb 8. Lancet. 2024. PMID: 38342126 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters